APR Sept/Oct 2023 - 26

Sartorius Stedim Biotech GmbH
August-Spindler-Straße 11
37079 Goettingen
Germany
Phone: +49.551.308.0
Fax: +49.551.308.3289
Email: info@sartorius-stedim.com
www.sartorius.com
Never has there been a more critical time to be a company
delivering technologies and expertise that helps get new biologics
and vaccines to patients faster. At Sartorius, we are that company.
Working in partnership with scientists, we help turn research
discoveries into real-world medicines. Our bioprocessing
equipment and services are called on daily to create biologics
that treat debilitating diseases, including cancer and arthritis, and
make affordable vaccines to prevent common infections. Global
organizations turn to us when they need assistance accelerating
production of new vaccines for pandemic viruses such as COVID-19,
Ebola, H1N1, and SARS-CoV-2.
Sartorius is the partner of choice in bioprocessing because we
offer innovative, groundbreaking solutions that life scientists
demand. In upstream processing, our Ambr® multi-parallel, mini
bioreactor systems allow rapid cell line selection and cell culture
process development. With our Biostat® STR and Biostat® RM
single-use bioreactors, scientists can achieve state-of-the-art seed
train expansion and seamless scale-up for intensified processing.
And to enable Bioprocess 4.0 smart manufacturing, there are
advanced analytical tools, including BioPAT® Spectro, for Raman
spectroscopy with Ambr® and Biostat STR® platforms coupled with
SIMCA® and MODDE® data analytics software.
Through recent acquisitions, we have also expanded our downstream
portfolio. We now provide reusable and single-use BioSMB multicolumn
chromatography systems for intensified purification of
proteins and CIM® monolithic chromatography columns uniquely
suited for the purification of large biomolecules like mRNA and
pDNA. Combining all these powerful tools in an end-to-end process
makes it simpler for scientists to discover and develop drugs more
rapidly, and safely speed up their biopharmaceutical manufacturing.
We understand that technology is only part of the solution for
creating quality biologics, so we underpin ours with technical
expertise and consultative support, giving researchers insights and
a deeper understanding of the science that matters. We continually
innovate in collaboration with industrial partners to optimize
tools, operations, and processes for increasing productivity. This
approach means we deliver real-world solutions to accelerate
drug discovery, translational research, and time to clinic, making a
significant impact on both affordability and accessibility of global
healthcare.
Don't just take our word for it. To see our innovations in action,
take a look in any leading global biopharmaceutical company and
CDMO. You'll see our technology there, working hand in hand with
the world's brightest scientists, simplifying progress to develop and
deliver medicines where and when they are needed most.
To find out how Sartorius can help you with simplifying progress, go
to www.sartorius.com
26 |
| September/October 2023
http://www.sartorius.com http://www.sartorius.com
APR Sept/Oct 2023

Table of Contents for the Digital Edition of APR Sept/Oct 2023
